Usana Health Sciences Sees FY23 Net Sales $900M-$950M Vs $940.57M Est
Portfolio Pulse from Benzinga Newsdesk
Usana Health Sciences has projected its net sales for FY23 to be between $900M and $950M, which is slightly lower than the estimated $940.57M.
July 25, 2023 | 8:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Usana Health Sciences' projected net sales for FY23 are slightly lower than the estimated $940.57M, which could potentially impact the company's stock price.
Usana Health Sciences' projected net sales for FY23 are slightly lower than the estimated $940.57M. This lower projection could potentially lead to a decrease in the company's stock price in the short term as it indicates that the company might not meet the market's expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100